Core Viewpoint - The company, Ailong Technology (688329.SH), has shown significant performance recovery in its Q3 2025 report, with substantial increases in revenue and net profit compared to the previous year [1] Financial Performance - The company's Q3 revenue reached 149 million yuan, marking an impressive year-on-year increase of 83.53% [1] - The net profit attributable to shareholders was 7.43 million yuan, reflecting a remarkable year-on-year growth of 182.09%, achieving quarterly profitability [1] Market Position and Product Coverage - Ailong Technology's products are now utilized in over 1,200 medical and health institutions across China, including more than 580 top-tier hospitals [1] - Among the top 50 ranked hospitals, over 30 have chosen Ailong's product series, indicating a strong market share and competitive position [1] Future Outlook - The company is expected to continue its performance improvement trend due to the ongoing expansion of its comprehensive product matrix and deeper overseas market penetration, alongside the wave of intelligent upgrades in medical supplies [1]